IMDX

Insight Molecular Diagnostics Inc.

Insider Trades

NameValueActionPriceCurrent Price
Broadwood Partners, L.p.10 Percent Owner
$913k250.9k shares
BuyApr 27, 2026
$3.64
--
Broadwood Partners, L.p.10 Percent Owner
Disclosure amount unavailable
BuyApr 27, 2026
--
--
Broadwood Partners, L.p.10 Percent Owner
Disclosure amount unavailable
BuyApr 24, 2026
--
--
Broadwood Partners, L.p.10 Percent Owner
$137k38.9k shares
BuyApr 24, 2026
$3.53
--
Broadwood Partners, L.p.10 Percent Owner
$982k280.4k shares
BuyApr 23, 2026
$3.50
--
Broadwood Partners, L.p.10 Percent Owner
Disclosure amount unavailable
BuyApr 23, 2026
--
--

News

globenewswire.comFavorable Head-to-Head Data on iMDx's GraftAssure with Competing NGS Assay Published in Clinical Chemistryglobenewswire.comJun 16globenewswire.comIMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantationglobenewswire.comJun 11globenewswire.comIMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantationglobenewswire.comJun 11seekingalpha.comInsight Molecular Diagnostics Inc. (IMDX) Shareholder/Analyst Call Prepared Remarks Transcriptseekingalpha.comJun 11globenewswire.comiMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congressglobenewswire.comJun 9